Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Cesca Therapeutics Inc.
(KOOL:NASDAQ)
Cesca Therapeutics to Announce Second Quarter Fiscal 2016 Results and Provide a Status Update to Investors on February 16, 2016 (2/11/2016)
view
StemCells Inc.
()
STANLIB Multi-Manager Medium Equity Fund of Funds A reaches new 52-Week Low (2/11/2016)
view
Celgene Corp.
(CELG:NASDAQ)
INSYS (INSY) Initiates Phase II Study for Infantile Spasms (2/10/2016)
view
Celgene Corp.
(CELG:NASDAQ)
Actelion (ALIOF) Misses Q4 Earnings, Revenue Estimates (2/10/2016)
view
Amarantus BioScience Holdings Inc.
(AMBS:OTCQB)
Amarantus BioScience Holdings, Inc., (OTCBB: AMBS) Has Received Orphan Drug Designation from the US FDA (2/11/2016)
view
Innovation Pharmaceuticals (Formerly known as Cellceutix Corp.)
(IPIX:OTC)
Cellceutix Meets With FDA for Phase 2 Clinical Trial of Kevetrin for Ovarian Cancer (2/10/2016)
view
Regeneus Ltd.
(RGS:ASX)
Reports Progenza stem cell therapy clears initial safety review (0/0/0000)
view
Athersys Inc.
()
Athersys' MultiStem® Data to be Presented at International Stroke Conference 2016 (2/10/2016)
view
Athersys Inc.
()
Athersys to Host Year End 2015 Financial Results Call (2/9/2016)
view
CorMedix Inc.
(CRMD:NYSE.MKT)
CorMedix Proprietary Antimicrobial Technology to be Featured at 14th Annual South Beach Symposium (2/10/2016)
view
Inovio Pharmaceuticals Inc.
(INO:NASDAQ)
These Two Companies Are Working On The Zika Virus Cure (2/9/2016)
view
Celgene Corp.
(CELG:NASDAQ)
Regeneron Q4 Earnings Lag, Gives 2016 View for Eylea Sales (2/9/2016)
view
Celgene Corp.
(CELG:NASDAQ)
Epizyme's Tazemetostat Gets Orphan Drug Status in the U.S. (2/9/2016)
view
Celgene Corp.
(CELG:NASDAQ)
Biotech ETFs Slide as Stocks Report Mixed Q4 Results (2/9/2016)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Announces Release Date For 2015 Full Year Results (2/10/2016)
view
Amarantus BioScience Holdings Inc.
(AMBS:OTCQB)
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia (2/10/2016)
view
Amarantus BioScience Holdings Inc.
(AMBS:OTCQB)
Amarantus to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference (2/9/2016)
view
Cesca Therapeutics Inc.
(KOOL:NASDAQ)
Texas Stem Cell Enters Into an Agreement With Cesca Therapeutics for Use of AutoXpress® Technology for Cord Blood Processing (2/9/2016)
view
RepliCel Life Sciences Inc.
(RP:TSX.V; REPCF:OTCQB)
RepliCel Life Sciences Announces Warrant Exercise Incentive Program (2/9/2016)
view
Nobilis Health Corp.
()
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Nobilis Health Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 21, 2016 - HLTH (2/8/2016)
view
Inovio Pharmaceuticals Inc.
(INO:NASDAQ)
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Working on a Zika Vaccine (2/9/2016)
view
Cipher Pharmaceuticals Inc.
(CPHR:NASDAQ; CPH:TSX)
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call (2/9/2016)
view
Innovation Pharmaceuticals (Formerly known as Cellceutix Corp.)
(IPIX:OTC)
Cellceutix to Submit Special Protocol Assessment Request to FDA for Phase 3 Clinical Study of Antibiotic Brilacidin for ABSSSI (2/9/2016)
view